A China-based precision oncology company focused on next-generation sequencing (NGS) cancer diagnostics and genomic profiling. Its tests are used by hospitals to guide targeted cancer therapies and by pharmaceutical companies to support clinical trials and drug development. Investors track the firm ...
No congressional trades have been disclosed for Burning Rock Biotech Limited (BNR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.